AI assistant
AGENUS INC — Director's Dealing 2013
Oct 3, 2013
34023_dirs_2013-10-03_652a0c9f-63c3-4e84-a6d2-98dc8dc017d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2013-10-01
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-01 | Common Stock | J | 4534 | $2.91 | Acquired | 1603489 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 43900 | Indirect |
Footnotes
F1: Represents issuance of stock for payment of 33% of Dr. Armen's base salary for September 2013.
F2: Dr. Armen is trustee and has investment authority for hte Garo Armen 2012 2 Year GRAT holding 39,854 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings")which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership of his pecuniary interest therein.